Literature DB >> 33831941

Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated with Belatacept.

Nathalie Chavarot1, Amani Ouedrani, Olivier Marion, Marianne Leruez-Ville, Estelle Villain, Maroua Baaziz, Arnaud Del Bello, Carole Burger, Rebecca Sberro-Soussan, Frank Martinez, Lucienne Chatenoud, Florence Abravanel, Dany Anglicheau, Jacques Izopet, Chloé Couat, Julien Zuber, Christophe Legendre, Fanny Lanternier, Nassim Kamar, Anne Scemla.   

Abstract

Year:  2021        PMID： 33831941     DOI： 10.1097/TP.0000000000003784

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  45 in total

1.  Time-Limited Therapy with Belatacept in Kidney Transplant Recipients.

Authors:  Thibault Letellier; Delphine Kervella; Abderrahmane Sadek; Christophe Masset; Claire Garandeau; Cynthia Fourgeux; Victor Gourain; Jeremie Poschmann; Gilles Blancho; Simon Ville
Journal:  J Clin Med       Date:  2022-06-06       Impact factor: 4.964

2.  Prospective, Longitudinal Study on Specific Cellular Immune Responses after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Kidney Transplant Recipients.

Authors:  Monika Lindemann; Charleen Baumann; Benjamin Wilde; Anja Gäckler; Lara Meller; Peter A Horn; Adalbert Krawczyk; Oliver Witzke
Journal:  Vaccines (Basel)       Date:  2022-05-26

3.  Long-term serological SARS-CoV-2 IgG kinetics following mRNA COVID-19 vaccine: real-world data from a large cohort of healthcare workers.

Authors:  Joana Oliveira-Silva; Teresa Reis; Cristiana Lopes; Ricardo Batista-Silva; Ricardo Ribeiro; Gilberto Marques; Vania Pacheco; Tiago Rodrigues; Alexandre Afonso; Vítor Pinheiro; Lucília Araújo; Fernando Rodrigues; Isabel Antunes
Journal:  Int J Infect Dis       Date:  2022-05-11       Impact factor: 12.074

4.  Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept.

Authors:  Michael T Ou; Brian J Boyarsky; Teresa P Y Chiang; Sunjae Bae; William A Werbel; Robin K Avery; Aaron A R Tobian; Allan B Massie; Dorry L Segev; Jacqueline M Garonzik-Wang
Journal:  Transplantation       Date:  2021-09-01       Impact factor: 5.385

5.  Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis.

Authors:  Kasama Manothummetha; Nipat Chuleerarux; Anawin Sanguankeo; Olivia S Kates; Nattiya Hirankarn; Achitpol Thongkam; M Veronica Dioverti-Prono; Pattama Torvorapanit; Nattapong Langsiri; Navaporn Worasilchai; Chatphatai Moonla; Rongpong Plongla; William M Garneau; Ariya Chindamporn; Pitchaphon Nissaisorakarn; Tany Thaniyavarn; Saman Nematollahi; Nitipong Permpalung
Journal:  JAMA Netw Open       Date:  2022-04-01

6.  Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation.

Authors:  Arnaud Del Bello; Nassim Kamar; Francois Vergez; Stanislas Faguer; Olivier Marion; Audrey Beq; Yasmine Lathrache; Florence Abravanel; Jacques Izopet; Emmanuel Treiner
Journal:  Kidney Int       Date:  2021-06-11       Impact factor: 10.612

7.  Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination.

Authors:  Gian Luca Salvagno; Brandon M Henry; Giovanni di Piazza; Laura Pighi; Simone De Nitto; Damiano Bragantini; Gian Luca Gianfilippi; Giuseppe Lippi
Journal:  Diagnostics (Basel)       Date:  2021-05-04

8.  Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?

Authors:  Giuseppe Lippi; Brandon Michael Henry; Mario Plebani
Journal:  Diagnostics (Basel)       Date:  2021-05-25

9.  Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.

Authors:  Edward J Carr; Andreas Kronbichler; Matthew Graham-Brown; Graham Abra; Christos Argyropoulos; Lorraine Harper; Edgar V Lerma; Rita S Suri; Joel Topf; Michelle Willicombe; Swapnil Hiremath
Journal:  Kidney Int Rep       Date:  2021-07-06

10.  Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.

Authors:  Patrice Chevallier; Marianne Coste-Burel; Amandine Le Bourgeois; Pierre Peterlin; Alice Garnier; Marie C Béné; Berthe-Marie Imbert; Thomas Drumel; Steven Le Gouill; Philippe Moreau; Beatrice Mahe; Viviane Dubruille; Nicolas Blin; Anne Lok; Cyrille Touzeau; Thomas Gastinne; Maxime Jullien; Sophie Vanthygem; Thierry Guillaume
Journal:  EJHaem       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.